GreenLight Biosciences Holdings (GRNA) Stock Price & Growth Analysis

Quote Panel

Updated September 14, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
45.43M
Shares Outstanding
151.68M
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.2995
Average Volume
684804
Beta
1.440043

Range
0.177-5.9
Industry
Biotechnology
Website
https://greenlightbiosciences.com
Sector
Healthcare

Quote Panel

Updated September 14, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

7.12x

P/S Ratio

0.82x

P/B Ratio

1.7

Debt/Equity

-2616.8%

Net Margin

$-1.1

EPS

How GRNA compares to sector?

P/E Ratio

Fundamentals

Relative Strength

GRNA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

GRNA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(N/A)

Number of analyst

Last analyst upgrade/downgrade

Canaccord Genuity

initialise

Previous: Not converted

2022-12-08

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.20

N/A

NA
vs NA

Q1.21

N/A

NA
vs NA

Q2.21

N/A

NA
vs NA

Q3.21

N/A

NA
vs NA

Q4.21

N/A

-0.23
vs -0.14

Q1.22

N/A

-0.34
vs -0.22

Q2.22

N/A

-0.42
vs -0.28

Q3.22

N/A

-0.27
vs -0.30

Q4.22

N/A

-0.26
vs -0.23

Q1.23

N/A

-0.19
vs -0.34

Sales Growth

YoY

Current

Estimates

Q4.20

NA vs NA

Q1.21

NA vs NA

Q2.21

NA vs NA

Q3.21

NA vs NA

Q4.21

NA vs NA

Q1.22

257K vs NA

Q2.22

1.7M vs NA

Q3.22

1.7M vs NA

Q4.22

2.9M vs NA

Q1.23

+1386%

3.8M vs 257K

Return on Equity

QoQ

Q4.20

NA
vs NA

Q1.21

-426%

-4.26
vs 0.13

Q2.21

-543%

-5.43
vs -4.26

Q3.21

+14%

0.14
vs -5.43

Q4.21

+35%

0.35
vs 0.14

Q1.22

-60%

-0.60
vs 0.35

Q2.22

-378%

-3.78
vs -0.60

Q3.22

-45%

-0.45
vs -3.78

Q4.22

-83%

-0.83
vs -0.45

Q1.23

-128%

-1.28
vs -0.83

Institutionnal Ownership

QoQ

Q1.21

NA
vs NA

Q2.21

NA
vs NA

Q3.21

NA
vs NA

Q4.21

1
vs NA

Q1.22

39
vs 1

3800%

Q2.22

49
vs 39

26%

Q3.22

57
vs 49

16%

Q4.22

60
vs 57

Q1.23

60
vs 60

Q2.23

45
vs 60

-25%

Earnings Growth

YoY

Current

Estimates

Q4.20

N/A

NA
vs NA

Q1.21

N/A

NA
vs NA

Q2.21

N/A

NA
vs NA

Q3.21

N/A

NA
vs NA

Q4.21

N/A

-0.23
vs -0.14

Q1.22

N/A

-0.34
vs -0.22

Q2.22

N/A

-0.42
vs -0.28

Q3.22

N/A

-0.27
vs -0.30

Q4.22

N/A

-0.26
vs -0.23

Q1.23

N/A

-0.19
vs -0.34

Sales Growth

YoY

Current

Estimates

Q4.20

NA vs NA

Q1.21

NA vs NA

Q2.21

NA vs NA

Q3.21

NA vs NA

Q4.21

NA vs NA

Q1.22

257K vs NA

Q2.22

1.7M vs NA

Q3.22

1.7M vs NA

Q4.22

2.9M vs NA

Q1.23

+1386%

3.8M vs 257K

Return on Equity

QoQ

Q4.20

NA
vs NA

Q1.21

-426%

-4.26
vs 0.13

Q2.21

-543%

-5.43
vs -4.26

Q3.21

+14%

0.14
vs -5.43

Q4.21

+35%

0.35
vs 0.14

Q1.22

-60%

-0.60
vs 0.35

Q2.22

-378%

-3.78
vs -0.60

Q3.22

-45%

-0.45
vs -3.78

Q4.22

-83%

-0.83
vs -0.45

Q1.23

-128%

-1.28
vs -0.83

Institutionnal Ownership

QoQ

Q1.21

NA
vs NA

Q2.21

NA
vs NA

Q3.21

NA
vs NA

Q4.21

1
vs NA

Q1.22

39
vs 1

3800%

Q2.22

49
vs 39

26%

Q3.22

57
vs 49

16%

Q4.22

60
vs 57

Q1.23

60
vs 60

Q2.23

45
vs 60

-25%

Company Description

0.30USD

N/A

7.12x

0.82x

1.7

-2616.8%

$-1.1

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Earnings Growth

Latest News

N/A

N/A

N/A

Company Description

0.30USD

N/A

7.12x

0.82x

1.7

-2616.8%

$-1.1